CRISPR Therapeutics AG (CRSP)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch CRSP
See up to 3 months of CRSP. The 7-day demo opens the 1M and 3M ranges and puts CRSP on your watchlist.
Start 7-day demoLatest CRSP insider trades
James R. Kasinger - OfficerOpen-market sale$119K- James R. Kasinger - OfficerOpen-market sale
About CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG is an SEC registrant, filing under CIK 0001674416, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
CRSP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 12,390 | $746K |
| Option exercise | 4 | 24,780 | |
| Bona-fide gift | 1 | 750 | |
CRSP insider transactions (Form 4)
7057 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James R. Kasinger - Officer | Option exercise | Common Shares | 1,990 | $13.62 | $27K | |
| James R. Kasinger - Officer | Open-market sale | Common Shares | 1,990 | $60.04 footnote F2 | $119K | |
| James R. Kasinger - Officer | Option exercise | Stock Option (Right to Buy) | 1,990 | $0.00 | - | |
| ||||||
| James R. Kasinger - Officer | Option exercise | Common Shares | 10,400 | $13.62 | $142K | |
| James R. Kasinger - Officer | Open-market sale | Common Shares | 10,400 | $60.24 footnote F3 | $626K | |
| James R. Kasinger - Officer | Option exercise | Stock Option (Right to Buy) | 10,400 | $0.00 | - | |
| ||||||
 Ali Behbahani - Director | Other | Common Shares | 60 | $0.00 | - | |
| Ali Behbahani - Director | Other | Common Shares | 15 | $0.00 | - | |
 Raju Prasad - Officer | Gift | Common Shares | 750 | $0.00 | - | |
| Simeon George | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Ali Behbahani | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
 Maria Fardis | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Harold Edward Fleming | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| John Greene | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Katherine A. High | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Sandesh Mahatme | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Briggs Morrison | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Christian Rommel | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Douglas A. Treco | Grant or award | Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| James R. Kasinger - Officer | Grant or award | Restricted Stock Units | 17,000 | $0.00 | - | |
 Naimish Patel - Officer | Grant or award | Restricted Stock Units | 22,000 | $0.00 | - | |
| Raju Prasad - Officer | Grant or award | Restricted Stock Units | 19,500 | $0.00 | - | |
| Naimish Patel - Officer | Option exercise | Common Shares | 10,000 | - footnote F1 | - | |
| Naimish Patel - Officer | Open-market sale | Common Shares | 3,786 footnote F2 | $55.62 | $211K | |
| Naimish Patel - Officer | Option exercise | Restricted Stock Units | 10,000 | - footnote F1 | - | |
| ||||||
| James R. Kasinger - Officer | Option exercise | Common Shares | 6,250 | - footnote F2 | - | |
| James R. Kasinger - Officer | Open-market sale | Common Shares | 3,182 footnote F3 | $46.78 | $149K | |
| James R. Kasinger - Officer | Grant or award | Stock Option (Right to Buy) | 38,499 | $0.00 | - | |
| James R. Kasinger - Officer | Grant or award | Restricted Stock Units | 25,000 | $0.00 | - | |
| James R. Kasinger - Officer | Option exercise | Restricted Stock Units | 6,250 | - footnote F2 | - | |
| ||||||
 Samarth Kulkarni - Officer | Option exercise | Common Shares | 19,687 | - footnote F2 | - | |
| Samarth Kulkarni - Officer | Open-market sale | Common Shares | 10,020 footnote F3 | $46.78 | $469K | |
| Samarth Kulkarni - Officer | Grant or award | Stock Option (Right to Buy) | 114,249 | $0.00 | - | |
| Samarth Kulkarni - Officer | Grant or award | Restricted Stock Units | 81,875 | $0.00 | - | |
| Samarth Kulkarni - Officer | Option exercise | Restricted Stock Units | 19,687 | - footnote F2 | - | |
| ||||||
| Raju Prasad - Officer | Option exercise | Common Shares | 6,250 | - footnote F2 | - | |
| Raju Prasad - Officer | Open-market sale | Common Shares | 3,708 footnote F3 | $46.78 | $173K | |
| Raju Prasad - Officer | Grant or award | Stock Option (Right to Buy) | 38,499 | $0.00 | - | |
| Raju Prasad - Officer | Grant or award | Restricted Stock Units | 27,500 | $0.00 | - | |
| Raju Prasad - Officer | Option exercise | Restricted Stock Units | 6,250 | - footnote F2 | - | |
| ||||||
| Naimish Patel - Officer | Grant or award | Stock Option (Right to Buy) | 38,499 | $0.00 | - | |
| Naimish Patel - Officer | Grant or award | Restricted Stock Units | 30,000 | $0.00 | - | |
| Naimish Patel - Officer | Option exercise | Common Shares | 8,125 | - footnote F2 | - | |
| Naimish Patel - Officer | Open-market sale | Common Shares | 3,150 footnote F4 | $48.26 | $152K | |
| Naimish Patel - Officer | Option exercise | Restricted Stock Units | 8,125 | - footnote F2 | - | |
| ||||||
| Raju Prasad - Officer | Option exercise | Common Shares | 10,000 | - footnote F2 | - | |
| Raju Prasad - Officer | Option exercise | Common Shares | 6,875 | - footnote F2 | - | |
| Raju Prasad - Officer | Open-market sale | Common Shares | 5,848 footnote F3 | $48.26 | $282K | |
| Raju Prasad - Officer | Open-market sale | Common Shares | 4,021 footnote F3 | $48.26 | $194K | |
| Raju Prasad - Officer | Gift | Common Shares | 750 | $0.00 | - | |
| Raju Prasad - Officer | Option exercise | Restricted Stock Units | 10,000 | - footnote F2 | - | |
| Raju Prasad - Officer | Option exercise | Restricted Stock Units | 6,875 | - footnote F2 | - | |
| ||||||
| James R. Kasinger - Officer | Option exercise | Common Shares | 6,875 | - footnote F2 | - | |
| James R. Kasinger - Officer | Open-market sale | Common Shares | 3,450 footnote F3 | $48.26 | $166K | |
| James R. Kasinger - Officer | Option exercise | Restricted Stock Units | 6,875 | - footnote F2 | - | |
| ||||||
| Samarth Kulkarni - Officer | Open-market sale | Common Shares | 10,349 footnote F3 | $48.26 | $499K | |
| Samarth Kulkarni - Officer | Option exercise | Common Shares | 20,625 | - footnote F2 | - | |
| Samarth Kulkarni - Officer | Option exercise | Restricted Stock Units | 20,625 | - footnote F2 | - | |
| ||||||
| James R. Kasinger - Officer | Option exercise | Restricted Stock Units | 5,500 | - footnote F2 | - | |
| James R. Kasinger - Officer | Option exercise | Common Shares | 5,500 | - footnote F2 | - | |
| James R. Kasinger - Officer | Open-market sale | Common Shares | 2,800 footnote F3 | $52.80 | $148K | |
| ||||||
| Samarth Kulkarni - Officer | Option exercise | Restricted Stock Units | 19,250 | - footnote F2 | - | |
| Samarth Kulkarni - Officer | Option exercise | Common Shares | 19,250 | - footnote F2 | - | |
| Samarth Kulkarni - Officer | Open-market sale | Common Shares | 9,798 footnote F3 | $52.80 | $517K | |
| ||||||
| Samarth Kulkarni - Officer | Option exercise | Common Shares | 13,250 | - footnote F1 | - | |
| Samarth Kulkarni - Officer | Open-market sale | Common Shares | 6,967 footnote F3 | $52.58 | $366K | |
| Samarth Kulkarni - Officer | Option exercise | Restricted Stock Units | 13,250 | - footnote F1 | - | |
| ||||||
| James R. Kasinger - Officer | Option exercise | Common Shares | 3,825 | - footnote F1 | - | |
| James R. Kasinger - Officer | Open-market sale | Common Shares | 2,112 footnote F2 | $52.58 | $111K | |
| James R. Kasinger - Officer | Option exercise | Restricted Stock Units | 3,825 | - footnote F1 | - | |
| ||||||
Item 2.02, 9.01
Item 5.02, 5.03, 5.07, 9.01
Item 2.02, 9.01
Item 1.01, 2.03, 3.02, 9.01
Recent CRSP Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JAMES KASINGER | Officer | 1,990 | $119K | View on EDGAR | |
| JAMES KASINGER | Officer | 10,400 |
CRSP insider trading FAQ
What is the latest insider trade for CRSP?
CRISPR Therapeutics AG (CRSP) had 4 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for CRSP runs to 57 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CRSP stock?
No insider purchases of CRSP were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling CRSP stock?
2 insider sales of CRSP were filed in the last 90 days, totaling $746K.
Where can I see CRSP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CRSP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - James R. Kasinger view on EDGAR
- - James R. Kasinger view on EDGAR
- - Ali Behbahani view on EDGAR
- - Raju Prasad view on EDGAR
- - Simeon George view on EDGAR
- - Ali Behbahani view on EDGAR
- - Maria Fardis view on EDGAR
- - Harold Edward Fleming view on EDGAR
- - John Greene view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CRSP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CRSP with a 7-day demo
- CRSP on your watchlist
- Every CRSP Form 4 filing on record
- Up to 3 months of CRSP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
